Table 1 Demographics of the studied patients
Control group No. = 30 | Patients group No. = 60 | p-value | Control group No. = 30 | DM only No. = 20 | Diabetic nephropathy No. = 20 | DM + cardiovascular No. = 20 | p-value | ||
|---|---|---|---|---|---|---|---|---|---|
Age (years) | Mean ± SD | 31.20 ± 7.77 | 55.00 ± 9.81 | < 0.0001 | 31.20 ± 7.77 | 50.55 ± 13.28 | 55.40 ± 7.76 | 59.05 ± 4.91 | < 0.0001 |
Gender | Female | 24 (80.0%) | 29 (48.3%) | 0.004 | 24 (80.0%) | 10 (50.0%) | 12 (60.0%) | 7 (35.0%) | 0.012 |
Male | 6 (20.0%) | 31 (51.7%) | 6 (20.0%) | 10 (50.0%) | 8 (40.0%) | 13 (65.0%) | |||
BMI (kg/m2) | Mean ± SD | 23.60 ± 4.23 | 29.32 ± 4.80 | < 0.0001 | 23.60 ± 4.23 | 31.39 ± 5.43 | 29.17 ± 4.00 | 27.40 ± 4.20 | < 0.0001 |
Duration (years) | Median | 10 (4 − 14) | 4.5 (4–10) | 7 (4–10) | 13.5 (11–15) | < 0.0001 | |||
Medication | Insulin | 22 (36.7%) | 2 (10.0%) | 4 (20.0%) | 16 (80.0%) | < 0.0001 | |||
OHG | 36 (60.0%) | 18 (90.0%) | 14 (70.0%) | 4 (20.0%) | |||||
Both | 2 (3.3%) | 0 (0.0%) | 2 (10.0%) | 0 (0.0%) | |||||
Comorbidity | No | 37 (61.7%) | 15 (75.0% | 10 (50.0% | 12 (60.0%) | 0.262 | |||
HTN | 23 (38.3%) | 5 (25.0% | 10 (50.0% | 8 (40.0%) | |||||